QUICK LINKS
MAIN MENU
CONNECT WITH US

Clinical Trial Details

Title
A Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment with BELVIQ (lorcaserin HCI) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects with Cardiovascular Disease or Multiple Cardiovascular Risk Factors CAMELLIA
Study Purpose
The main purpose of this research study is to assess whether lorcaserin HCl (brand name BELVIQ®) affects the risk of developing cardiovascular diseases in men and women at higher risk of developing these diseases.
Study Plan
Subjects will be randomized to study drug or placebo.
Investigators

Principal Investigator
Dominick J. Angiolillo, M.D., Ph.D., FACC
Medicine

Sub Investigator
Theodore A. Bass, M.D.
Medicine

Sub Investigator
Martin "M" Zenni, M.D.
Medicine

Meeting Schedule & Submission Deadlines

Note: All submissions for IRB review require a single electronic copy of all documents to be emailed and a single (signed) original hardcopy be provided to the IRB office. The IRB cannot log in the submission until the paper copy is received.

Resources

News & Announcements

Groundbreaking stem cell research could treat deadly diseases - Thumb

Groundbreaking stem cell research could treat deadly diseases

9/14/2017

Functional fat cells may play a role in regenerative medicine. What if liposuction could undo the damage caused by degenerative condit... [full story]

UF COMJ researchers part of $2.1 million award to study weight loss interventions in primary care settings - Thumb

UF COMJ researchers part of $2.1 million award to study weight loss interventions in primary care settings

9/7/2017

Funds awarded by the Patient-Centered Outcomes Research Institute Researchers at the University of Florida College of Medicine –... [full story]

COMJ faculty mourn loss of esteemed colleague  - Thumb

COMJ faculty mourn loss of esteemed colleague

7/21/2017

Robert Wears, MD, PhD, was regarded as an expert in patient safety As faculty members toggle grief and shock over the death of Robert... [full story]

Upcoming Events

Nov 28

IRB Meeting

From 12:00 PM until 2:00 PM

Dec 12

IRB Meeting

From 12:00 PM until 2:00 PM